Tue, September 18, 2012
Mon, September 17, 2012
Sun, September 16, 2012
Fri, September 14, 2012
Thu, September 13, 2012
Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012

Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 1


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. hcare-conference-in-new-york-on-september-1.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In... -- DUBLIN, Sept. 6, 2012 /PRNewswire/ --

Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11

[ ]

DUBLIN, Sept. 6, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: [ JAZZ ]) announced today that the company will participate at the 2012 Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 11, 2012 at 9:45 a.m. EST / 2:45 p.m. GMT. Kate Falberg, executive vice president and chief financial officer, will provide a business update during a question and answer session with an analyst.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at [ www.jazzpharmaceuticals.com ]. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of webcast will be available for at least one week on the Investors section of the company's website at [ www.jazzpharmaceuticals.com ].

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain, psychiatry and women's health. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate), Erwinaze™ (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, FazaClo® (clozapine USP) HD and LD, Luvox CR® (fluvoxamine maleate) and Elestrin® (estradiol gel 0.06%). Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by an international division, EUSA Pharma.

SOURCE Jazz Pharmaceuticals plc



[ Back to top ]

RELATED LINKS
[ http://www.jazzpharmaceuticals.com ]


Publication Contributing Sources